Helping Cancer Patients

Medical cannabis can meaningfully help cancer patients manage symptoms. In an 8-week Johns Hopkins case study of 25 advanced cancer patients, adding medical marijuana to treatment regimens produced a 45% reduction in pain scores, a 38% reduction in nausea, and a measurable drop in opioid use — while improving sleep, appetite, and quality of life.

The Study and Its Results

Published in the Journal of Palliative Medicine and conducted at Johns Hopkins University, the study followed 25 advanced cancer patients over 8 weeks as they added medical marijuana to their existing treatment regimens. The results were significant across nearly every symptom measured:

• Pain: 45% improvement in pain scores on a 10-point scale, and a 35% reduction in breakthrough pain episodes — allowing reduced reliance on opioids.
• Opioid use: average daily opioid consumption declined from 60 MME per day to 45 MME per day.
• Nausea: average reduction of 38%; 60% of patients using cannabis for chemotherapy nausea were able to stop other anti-nausea medications completely.
• Appetite and weight: the appetite-stimulant effects of THC led to an average weight gain of 4.5 pounds over the 8 weeks, helping prevent cachexia and wasting.
• Sleep: 42% improvement in sleep quality scores, 52% reduction in nighttime awakenings, and 37% less daytime drowsiness.

What This Means for Symptom Management

For cancer patients, the numbers translate into everyday relief: less pain between doses, fewer nausea episodes after chemotherapy, steadier appetite and weight, and more restorative sleep with fewer interruptions.

The opioid finding is particularly notable — a 25% reduction in average daily opioid use (from 60 MME to 45 MME) suggests cannabis may serve as a useful adjunct that helps patients lower their reliance on opioids, which carry risks of dependence and respiratory depression.

More Research Is Still Needed

Researchers still need to pin down the optimal strains, dosages, and cannabinoid profiles for different cancer types and symptoms. This study was a small case series, so its results should be viewed as promising evidence rather than settled guidance.

A Role in Integrative Cancer Care

Oncologists and healthcare providers should keep cannabis's potential benefits in mind when developing integrative treatment plans with their patients. Patients interested in adding medical marijuana to their protocol should speak with their healthcare team about the risks and benefits for their individual situation — especially since cannabis can interact with other medications.

This is general information, not medical advice. Cancer treatment decisions should always be made with your oncology care team.